Planned Mode of Delivery After Caesarean: a Comparative Prospective National Population-based Cohort Study
CICAMODA
1 other identifier
observational
16,764
1 country
1
Brief Summary
In women with one previous caesarean, the choice of mode of delivery is determined by a shared decision-making process between the women and the obstetrician, with the two options being a trial of labour after caesarean (TOLAC) or an elective repeat caesarean delivery (ERCD). To date, the scientific literature has reported of higher perinatal morbidity-mortality with TOLAC, although with low absolute risks and discordant results about maternal morbidity-mortality. These studies suffer from limitations, as they include women with more than one previous caesarean or with high rates of failed TOLAC, which are two risk factors for uterine rupture, and the definition of planned versus effective mode of delivery is not precise in most studies. However, scientific societies recommend that most women with one previous caesarean should be offered TOLAC because of the low absolute perinatal risk of this option and the high maternal and perinatal risk associated with an ERCD in the short- and long-term. Conversely, the investigators hypothesise that TOLAC would be not inferior to ERCD in women with one previous caesarean in terms of perinatal morbidity-mortality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 2, 2022
CompletedFirst Posted
Study publicly available on registry
June 30, 2022
CompletedStudy Start
First participant enrolled
June 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 13, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
January 13, 2026
CompletedAugust 3, 2026
July 1, 2026
2.6 years
June 2, 2022
July 31, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
The primary endpoint will be the perinatal morbidity-mortality rate
Composite measure of: * Perinatal death (any foetal death or death of a liveborn infant before hospital discharge \[excluding lethal congenital anomalies\]) * Birth trauma * SARNAT Stage 2 or 3 hypoxic ischemic encephalopathy * Perinatal asphyxia, which is fulfilment of at least one of the following criteria: * Severe biological signs: pH \< 7,0 or Lactate ≥ 11 mmol/L * Or 7.0 \< pH ≤ 7.15, or 8 ≤ lactates \< 11 mmol/l, or not available but with: * Perinatal event (severe non reassuring fetal hearth rate, cord prolapse, uterine rupture, maternal trauma or cardio-respiratory arrest * Or sudden change of fetal hearth rate * Or 10 minutes Apgar score of 5 or less or assisted ventilation initiated at birth and continued for at least 10 minutes * Admission to intensive care with intratracheal intubation or need for ventilation * Length of stay in Neonatal Intensive \> 4 days * Neonatal respiratory distress syndrome * Proven early neonatal sepsis bacterial infection
From admission and maximum 28 days after delivery
Secondary Outcomes (8)
Maternal morbidity-mortality rate
From admissionand maximum 15 days after delivery
Uterine rupture rate
During the surgery and confirmed by an adjudication committee.
Breastfeeding rate at the time of hospital discharge
Between day 3 and day 5
Felt pain during delivery
6-weeks postpartum
Breastfeeding rate
6-weeks postpartum
- +3 more secondary outcomes
Study Arms (2)
Exposed group
Women with a history of cesarean section and with a base-line attempt after planned cesarean section (TVBAC).
Non-exposed group
Women with a history of cesarean section and scheduled cesarean section after cesarean section (CPAC).
Interventions
Women will be asked to complete questionnaires 6 weeks after delivery
Eligibility Criteria
Pregnant women age of 18 years or older
You may qualify if:
- Pregnant women age of 18 years or older
- Women admitted to the labour ward at gestational age ≥ 34 weeks
- Women with a singleton pregnancy
- Women with one previous caesarean delivery
You may not qualify if:
- Women who oppose to participation in the study
- Age \< 18 years
- Women admitted to the labour ward at gestational age \< 34 weeks
- Women with multiple pregnancy
- Women with more than one previous caesarean or more than one uterine scar
- Women who do not understand the French language
- Women under judicial protection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assistance Publique Hôpitaux Marseille
Marseille, Bouches-du-rhône, 13354, France
Study Officials
- STUDY DIRECTOR
François CREMIEUX
ASSITANCE PUBLIQUE HOPITAUX MARSEILLE
- PRINCIPAL INVESTIGATOR
Julie BLANC
ASSITANCE PUBLIQUE HOPITAUX MARSEILLE
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 2, 2022
First Posted
June 30, 2022
Study Start
June 22, 2023
Primary Completion
January 13, 2026
Study Completion
January 13, 2026
Last Updated
August 3, 2026
Record last verified: 2026-07